Literature DB >> 22889543

Human arboviral encephalitis.

Robert S Rust1.   

Abstract

Worldwide, arboviral illnesses constitute the most important international infectious threat to human neurological health and welfare. Before the availability of effective immunizations, approximately 50,000 cases of Japanese encephalitis occurred in the world each year, one-fifth of which cases proved lethal and a much larger number were left with severe neurological handicaps. With global climate change and perhaps other factors, the prevalences of some arboviral illnesses appear to be increasing. Arboviral illnesses, including Japanese encephalitis, tick-borne encephalitis, Yellow fever, and others, are emerging as possible global health care threats because of biological warfare. This chapter will review ecology, pathophysiology, diagnosis, management, and outcome of the forms of arboviral encephalitis that are of greatest importance in North America, together with some of the most important arboviral encephalitides prevalent in other parts of the world.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889543     DOI: 10.1016/j.spen.2012.03.002

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  12 in total

1.  Death and gastrointestinal bleeding complicate encephalomyelitis in mice with delayed appearance of CNS IgM after intranasal alphavirus infection.

Authors:  Victoria K Baxter; Elizabeth M Troisi; Nathan M Pate; Julia N Zhao; Diane E Griffin
Journal:  J Gen Virol       Date:  2018-03       Impact factor: 3.891

2.  Flaviviruses as a Cause of Undifferentiated Fever in Sindh Province, Pakistan: A Preliminary Report.

Authors:  Erum Khan; Joveria Q Farooqi; Kelli L Barr; Dhani Prakoso; Amna Nasir; Akbar Kanji; Sadia Shakoor; Faisal Riaz Malik; Rumina Hasan; John A Lednicky; Maureen T Long
Journal:  Front Public Health       Date:  2016-02-16

3.  Snowshoe Hare Virus Causing Meningoencephalitis in a Young Adult From Northern Manitoba, Canada.

Authors:  Lawrence Lau; Beverly Wudel; Kamran Kadkhoda; Yoav Keynan
Journal:  Open Forum Infect Dis       Date:  2017-07-22       Impact factor: 3.835

4.  Impact of environmental factors on neglected emerging arboviral diseases.

Authors:  Camila Lorenz; Thiago S Azevedo; Flávia Virginio; Breno S Aguiar; Francisco Chiaravalloti-Neto; Lincoln Suesdek
Journal:  PLoS Negl Trop Dis       Date:  2017-09-27

5.  Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected.

Authors:  Stephanie L Cumberworth; Jennifer A Barrie; Madeleine E Cunningham; Daniely Paulino Gomes de Figueiredo; Verena Schultz; Adrian J Wilder-Smith; Benjamin Brennan; Lindomar J Pena; Rafael Freitas de Oliveira França; Christopher Linington; Susan C Barnett; Hugh J Willison; Alain Kohl; Julia M Edgar
Journal:  Acta Neuropathol Commun       Date:  2017-06-23       Impact factor: 7.801

Review 6.  The potential role of Wolbachia in controlling the transmission of emerging human arboviral infections.

Authors:  Joseph Kamtchum-Tatuene; Benjamin L Makepeace; Laura Benjamin; Matthew Baylis; Tom Solomon
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

Review 7.  A Review: Aedes-Borne Arboviral Infections, Controls and Wolbachia-Based Strategies.

Authors:  Samson T Ogunlade; Michael T Meehan; Adeshina I Adekunle; Diana P Rojas; Oyelola A Adegboye; Emma S McBryde
Journal:  Vaccines (Basel)       Date:  2021-01-08

Review 8.  Innate immune sensing of flaviviruses.

Authors:  Mehul S Suthar; Sebastian Aguirre; Ana Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

Review 9.  The Clinical Approach to Encephalitis.

Authors:  Amanda L Piquet; Tracey A Cho
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 6.030

Review 10.  Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.

Authors:  Hamid Salimi; Matthew D Cain; Robyn S Klein
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.